Design Therapeutics Inc
NASDAQ:DSGN
Income Statement
Earnings Waterfall
Design Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-78.2m
USD
|
Operating Income
|
-78.2m
USD
|
Other Expenses
|
11.3m
USD
|
Net Income
|
-66.9m
USD
|
Income Statement
Design Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(13)
|
(25)
|
(36)
|
(44)
|
(51)
|
(59)
|
(68)
|
(76)
|
(83)
|
(82)
|
(78)
|
|
Selling, General & Administrative |
(4)
|
(7)
|
(11)
|
(14)
|
(16)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(21)
|
|
Research & Development |
(9)
|
(17)
|
(25)
|
(30)
|
(36)
|
(42)
|
(49)
|
(56)
|
(61)
|
(60)
|
(57)
|
|
Operating Income |
(13)
N/A
|
(25)
-85%
|
(36)
-45%
|
(44)
-21%
|
(51)
-18%
|
(59)
-15%
|
(68)
-14%
|
(76)
-12%
|
(83)
-9%
|
(82)
+0%
|
(78)
+5%
|
|
Pre-Tax Income | ||||||||||||
Total Other Income |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
7
|
9
|
10
|
11
|
|
Pre-Tax Income |
(13)
N/A
|
(24)
-86%
|
(36)
-45%
|
(43)
-22%
|
(51)
-17%
|
(57)
-13%
|
(63)
-11%
|
(69)
-10%
|
(74)
-7%
|
(72)
+3%
|
(67)
+8%
|
|
Net Income | ||||||||||||
Income from Continuing Operations |
(13)
|
(24)
|
(36)
|
(43)
|
(51)
|
(57)
|
(63)
|
(69)
|
(74)
|
(72)
|
(67)
|
|
Net Income (Common) |
(13)
N/A
|
(24)
-86%
|
(36)
-45%
|
(43)
-22%
|
(51)
-17%
|
(57)
-13%
|
(63)
-11%
|
(69)
-10%
|
(74)
-7%
|
(72)
+3%
|
(67)
+8%
|
|
EPS (Diluted) |
-0.23
N/A
|
-0.44
-91%
|
-0.77
-75%
|
-0.79
-3%
|
-0.92
-16%
|
-1.03
-12%
|
-1.14
-11%
|
-1.25
-10%
|
-1.34
-7%
|
-1.3
+3%
|
-1.19
+8%
|